Fig. 5
From: Cuproptosis-related lncRNA predict prognosis and immune response of lung adenocarcinoma
The prognostic value of the signature for LUAD. a Univariate and b multivariate independent prognostic analysis to analyze that the risk score was independently associated with OS. 1-, 3-, and 5-year area under the ROC curve (AUC) of signature in the c training, d testing, and e all groups. f ROC curves for the riskscore (AUC=0.756) and other clinical features